| Application no. and date | 15824955.7 (espacenet) (Federated) (European Patent Register), 20150720 | | Patent/reg. no. and date | DK/EP 3172227, 20190904 | | Publication date | 20170531 | | Priority no. and date | US 201461999241 P, 20140721 | | EP pub. no. and date |
EP 3172227 20170531 | | Effective date | | | Applicant/owner | Delinia, Inc., 400 Technology Square
10th Floor
Cambridge, Massachusetts 02139, US | | Applicant ref. no. | P70179DK01 | | Inventor | GREVE,Jeffrey, 1066 Park Hills Road
Berkeley, California 94708, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C07K 14/55 (2006.01) , A61K 38/00 (2006.01) , C07K 16/00 (2006.01) | | Title | MOLEKYLER DER SELEKTIVT AKTIVERER REGULATORISKE T-CELLER TIL BEHANDLINGEN AF AUTOIMMUNE SYGDOMME | | Int. application no. | US2015041177 | | Int. publication no. | WO2016014428 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
